Pharmstandard posts 1H 2009 Net Profit of 2.59 billion Roubles
The leading Russian pharmaceutical company, Pharmstandard has posted a 1H 2009 Net Profit of 2.59 billion Roubles under IFRS.
The bottom line is up 47% from the 1H 2008 Net Result of 1.76 billion Roubles, with EBITDA up 51% year on year to 3.9 billion Roubles, as Revenues rose 62% to 10.1 billion Roubles.
The company largely attributed its better than expected results to the governmental tender for Velcade supply held in 2Q 2009, which boosted pharmaceutical products sales for Pharmstandard by 73% in 1H 2009 year on year.
You can share this story on social media:
Follow RT on
Dear readers! Thank you for your vibrant engagement with our content and for sharing your points of view. Please note that we have switched to a new commenting system. To leave comments, you will need to register. We are working on some adjustments so if you have questions or suggestions feel free to send them to feedback@rttv.ru. Please check our commenting policy. Happy holidays to you all! Question More
